Search AMIA.org

Pharmacogenomics can optimize therapeutic outcomes while minimizing adverse events. However, the lack of trained healthcare professionals has impeded its widespread adoption. Current patient-facing applications are either institution-specific or vary significantly in their coverage of genetic variants, interpretation guidelines, and data privacy protection. To address these shortcomings, we developed PharMe.

Generating real-world evidence (RWE) approaches across federated evidence networks based on real-world data requires learning new methodological skills. However, standardized frameworks for defining and assessing competencies for large-scale RWE research remain limited. This study aims to develop an assessment framework for RWE studies and evaluate the competencies of RWE research professionals.

Electronic health record (EHR) data discontinuity, defined as receiving care outside of a particular EHR system, may cause misclassification of study variables. We aimed to: (1) quantify misclassification across levels of EHR data discontinuity and identify an optimal continuity threshold, (2) develop a machine learning (ML) model to predict EHR continuity and optimize fairness across racial and ethnic groups, and (3) externally validate the EHR continuity prediction model using an [...]

To describe the development and implementation of an automated platform for genomic risk prediction that integrates multiple data types.

Atrial fibrillation (AF) is a common arrhythmia affecting a large fraction of patients in intensive care units (ICUs). Predicting patients at risk of AF in the ICU is a challenging task and is not commonly practiced but could have clinical implications considering that AF is a proxy for poorer outcomes. Our goal is to develop a real-time AF prediction model using ICU numerical data to improve alarm quality, helping clinicians [...]

To develop a pipeline for evaluating large language models (LLMs) on the task of capturing symptoms from clinical encounters.

To systematically map co-occurrence patterns between systemic medical conditions and oral diseases in the biomedical literature.

Develop and validate subtype-specific, fairness-aware machine learning (ML) models that integrate clinical and social determinants of health (SDoH) information to predict 6-month readmission or mortality after hospitalization among patients with HFpEF or HFrEF, and to evaluate the incremental contribution of SDoH, model explainability, and subgroup error disparities across demographic groups.

To analyze oncology nurses' accounts of technology-related safety events and the sociotechnical factors contributing to patient-, workforce-, and system-level harms.

Implementing target trial emulation (TTE) studies as standardized, reproducible analytic workflows is technically demanding. We developed Text-guided Health-study Estimation and Specification Engine Using Strategus (THESEUS), which uses large language models (LLMs) to translate free-text study descriptions into structured analytic specifications and Strategus R scripts within the Observational Health Data Sciences and Informatics (OHDSI) ecosystem.